US2016193291A1PendingUtilityA1
Method of regulating neuronal axon elongation
Est. expiryApr 26, 2032(~5.8 yrs left)· nominal 20-yr term from priority
A61K 48/00A61K 38/177G01N 33/5058A61K 48/005A61K 31/4965C07H 21/04
43
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention includes a treating step of treating neuronal growth cone with a regulatory factor to regulate macropinocytosis caused by a repulsive axon guidance molecule. The present invention can provide a new neuronal axon elongation regulating method etc.
Claims
exact text as granted — not AI-modified1 . A method of increasing neuronal axon elongation, comprising:
a treating step of treating neuronal growth cone with a regulatory factor to reduce macropinocytosis caused by a repulsive axon guidance molecule, the treating step inducing promotion of the axon elongation as a result of reducing the macropinocytosis, wherein the regulatory factor is an inhibitor of a sodium/proton exchanger being present in the growth cone.
2 . (canceled)
3 . The method as set forth in claim 1 ,
wherein the inhibitor is 5-(N-ethyl-N-isopropyl)amiloride or an analog thereof.
4 - 6 . (canceled)
7 . The method as set forth in claim 1 ,
wherein the treating step comprises an administering step of administering an effective amount of the regulatory factor to a human or non-human animal, wherein the human or non-human animal is one suffering damage to a nervous system thereof or is to undergo an operation on its nervous system thereof.
8 - 12 . (canceled)
13 . The method as set forth in claim 3 ,
wherein the inhibitor is 5-(N-ethyl-N-isopropyl)amiloride.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.